U. Gräfe

3.8k total citations
181 papers, 2.9k citations indexed

About

U. Gräfe is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, U. Gräfe has authored 181 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pharmacology, 86 papers in Molecular Biology and 37 papers in Organic Chemistry. Recurrent topics in U. Gräfe's work include Microbial Natural Products and Biosynthesis (83 papers), Fungal Biology and Applications (50 papers) and Marine Sponges and Natural Products (14 papers). U. Gräfe is often cited by papers focused on Microbial Natural Products and Biosynthesis (83 papers), Fungal Biology and Applications (50 papers) and Marine Sponges and Natural Products (14 papers). U. Gräfe collaborates with scholars based in Germany, Austria and Russia. U. Gräfe's co-authors include Brigitte Schlegel, Albrecht Berg, W. F. Fleck, I. Eritt, Albert Härtl, G. Reinhardt, M. RITZAU, Hans‐Martin Dahse, K. Dornberger and H. Thrum and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

U. Gräfe

178 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Gräfe Germany 31 1.6k 1.3k 789 517 489 181 2.9k
NOBORU OTAKE Japan 31 1.3k 0.8× 1.8k 1.4× 1.4k 1.7× 372 0.7× 365 0.7× 224 3.4k
TAMOTSU FURUMAI Japan 33 2.0k 1.3× 1.6k 1.2× 1.1k 1.4× 785 1.5× 647 1.3× 144 3.4k
MASATAKA KONISHI Japan 36 1.4k 0.9× 2.1k 1.6× 2.3k 2.9× 465 0.9× 256 0.5× 111 4.3k
Deborah L. Zink United States 40 2.3k 1.5× 2.3k 1.8× 1.8k 2.3× 766 1.5× 545 1.1× 138 4.9k
Rokuro Masuma Japan 37 1.7k 1.1× 1.7k 1.3× 882 1.1× 633 1.2× 604 1.2× 140 3.7k
W. Keller‐Schierlein Germany 34 1.4k 0.9× 1.6k 1.3× 1.3k 1.6× 387 0.7× 492 1.0× 136 3.5k
Masakazu Uramoto Japan 29 928 0.6× 1.4k 1.1× 816 1.0× 348 0.7× 363 0.7× 115 2.4k
YUZURU IWAI Japan 37 1.8k 1.2× 2.1k 1.6× 1.4k 1.8× 740 1.4× 620 1.3× 138 4.3k
Charlotte H. Gotfredsen Denmark 31 810 0.5× 1.9k 1.5× 714 0.9× 451 0.9× 944 1.9× 123 3.4k
Hiranthi Jayasuriya United States 30 1.0k 0.7× 1.1k 0.9× 864 1.1× 312 0.6× 440 0.9× 59 2.5k

Countries citing papers authored by U. Gräfe

Since Specialization
Citations

This map shows the geographic impact of U. Gräfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Gräfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Gräfe more than expected).

Fields of papers citing papers by U. Gräfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Gräfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Gräfe. The network helps show where U. Gräfe may publish in the future.

Co-authorship network of co-authors of U. Gräfe

This figure shows the co-authorship network connecting the top 25 collaborators of U. Gräfe. A scholar is included among the top collaborators of U. Gräfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Gräfe. U. Gräfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Желифонова, В. П., et al.. (2004). [Isolation of Penicillium DIERCKX 1901--a producer of diketopiperazine alkaloids rokefortin and 3,12-dihydrokefortin--from permafrost].. PubMed. 39(4). 446–51. 1 indexed citations
2.
Degenkolb, Thomas, Albrecht Berg, W. Gams, Brigitte Schlegel, & U. Gräfe. (2003). The occurrence of peptaibols and structurally related peptaibiotics in fungi and their mass spectrometric identification via diagnostic fragment ions. Journal of Peptide Science. 9(11-12). 666–678. 106 indexed citations
3.
Grigoriev, Pavel A., et al.. (2003). Differences in membrane pore formation by peptaibols. Journal of Peptide Science. 9(11-12). 763–768. 30 indexed citations
4.
Berg, Albrecht, Pavel A. Grigoriev, Thomas Degenkolb, et al.. (2003). Isolation, structure elucidation and biological activities of trichofumins A, B, C and D, new 11 and 13mer peptaibols from Trichoderma sp. HKI 0276. Journal of Peptide Science. 9(11-12). 810–816. 32 indexed citations
5.
Rosner, H., W Erler, U. Gräfe, et al.. (2002). Effects of the mycotoxin ochratoxin A and some of its metabolites on the human cell line THP-1. Toxicology. 184(1). 69–82. 56 indexed citations
6.
Hoshino, Yasutaka, Katsukiyo Yazawa, Akikazu Ando, et al.. (2002). Queenslandon, a New Antifungal Compound Produced by Chrysosporium queenslandicum: Production, Isolation and Structure Elucidation.. The Journal of Antibiotics. 55(5). 516–519. 22 indexed citations
7.
Berg, Albrecht, Johannes Notni, Heinrich Dörfelt, & U. Gräfe. (2002). Acremonol and Acremodiol, New Fungal Bislactones.. The Journal of Antibiotics. 55(7). 660–662. 13 indexed citations
8.
Jütten, Peter, et al.. (2002). Synthesis and biological activity of chiral tetrahydrofuranyl amino acids as building moieties of pamamycin analogues.. PubMed. 57(1). 34–40.
9.
Heinze, Thomas M., et al.. (2001). Synthesis of a New Polycyclic Quinone by Reduction of a Dihydrobenzo[a]naphthacenequinone.. The Journal of Antibiotics. 54(2). 191–192. 2 indexed citations
10.
Schlegel, Brigitte, et al.. (2001). Ampullosporins B, C, D, E1, E2, E3, and E4, from Sepedonium ampullosporum HKI-0053. Structures and Biological Activities.. The Journal of Antibiotics. 54(2). 175–178. 24 indexed citations
12.
Gräfe, U., R. Schlegel, M. RITZAU, et al.. (1995). Aurantimycins, New Depsipeptide Antibiotics from Streptomyces aurantiacus IMET 43917 Production, Isolation, Structure Elucidation, and Biological Activity.. The Journal of Antibiotics. 48(2). 119–125. 52 indexed citations
13.
Bushell, Michael E. & U. Gräfe. (1989). Bioactive metabolites from microorganisms : selected papers from the 2nd International Symposium on New Bioactive Metabolites from Microorganisms, Gera, GDR, May 2-7, 1988. Elsevier eBooks. 2 indexed citations
14.
Hänel, F., et al.. (1985). Influence of inorganic phosphate on the lipid synthesis of a phosphate‐deregulated mutant of Streptomyces noursei. Journal of Basic Microbiology. 25(5). 325–333. 5 indexed citations
15.
Breunig, H.J. & U. Gräfe. (1984). Trialkylbismutine als Liganden in Carbonylkomplexen des Eisens und der VIa‐Elemente. Zeitschrift für anorganische und allgemeine Chemie. 510(3). 104–108. 14 indexed citations
16.
Friedrich, W, et al.. (1984). Isolation and biological properties of arsenate‐resistant strains of Streptomyces noursei. Zeitschrift für allgemeine Mikrobiologie. 24(1). 13–19. 6 indexed citations
17.
Friedrich, W, et al.. (1984). Isolation and biological properties of arsenate-resistant strains ofStreptomyces noursei. Journal of Basic Microbiology. 24(1). 13–19. 10 indexed citations
18.
Gräfe, U., et al.. (1984). Modification by genetic changes of the pleiotropic interference of butyrolactone-type autoregulators with differentiation ofStreptomyces griseus. Journal of Basic Microbiology. 24(8). 515–523. 4 indexed citations
19.
Gräfe, U.. (1983). Sekundärmetabolite als endogene Effektoren der mikrobiellen Cytodifferenzierung. Journal of Basic Microbiology. 23(5). 319–343. 6 indexed citations
20.
Gräfe, U.. (1983). Sekundärmetabolite als endogene Effektoren der mikrobiellen Cytodifferenzierung. Zeitschrift für allgemeine Mikrobiologie. 23(5). 319–343. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026